155 related articles for article (PubMed ID: 16170352)
1. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.
Vera J; Jaumot M; Estanyol JM; Brun S; Agell N; Bachs O
Oncogene; 2006 Jan; 25(2):260-70. PubMed ID: 16170352
[TBL] [Abstract][Full Text] [Related]
2. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A.
Hunt TA; Urbanowski MD; Kakani K; Law LM; Brinton MA; Hobman TC
Cell Microbiol; 2007 Nov; 9(11):2756-66. PubMed ID: 17868381
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.
Tsujio I; Zaidi T; Xu J; Kotula L; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2005 Jan; 579(2):363-72. PubMed ID: 15642345
[TBL] [Abstract][Full Text] [Related]
4. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity.
Carujo S; Estanyol JM; Ejarque A; Agell N; Bachs O; Pujol MJ
Oncogene; 2006 Jul; 25(29):4033-42. PubMed ID: 16474839
[TBL] [Abstract][Full Text] [Related]
5. Increased chromatin association of Sp1 in interphase cells by PP2A-mediated dephosphorylations.
Vicart A; Lefebvre T; Imbert J; Fernandez A; Kahn-Perlès B
J Mol Biol; 2006 Dec; 364(5):897-908. PubMed ID: 17049555
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein I-2PP2A/SET negatively regulates the MEK/ERK pathway and cell proliferation.
Fukukawa C; Shima H; Tanuma N; Okada T; Kato N; Adachi Y; Kikuchi K
Int J Oncol; 2005 Mar; 26(3):751-6. PubMed ID: 15703833
[TBL] [Abstract][Full Text] [Related]
7. Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.
Chohan MO; Khatoon S; Iqbal IG; Iqbal K
FEBS Lett; 2006 Jul; 580(16):3973-9. PubMed ID: 16806196
[TBL] [Abstract][Full Text] [Related]
8. Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET.
ten Klooster JP; Leeuwen Iv; Scheres N; Anthony EC; Hordijk PL
EMBO J; 2007 Jan; 26(2):336-45. PubMed ID: 17245428
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the mTOR alpha4 phosphoprotein activates protein phosphatase 2A and increases Stat1alpha binding to PIAS1.
Nien WL; Dauphinee SM; Moffat LD; Too CK
Mol Cell Endocrinol; 2007 Jan; 263(1-2):10-7. PubMed ID: 17084018
[TBL] [Abstract][Full Text] [Related]
10. Identification of PP2A as a novel interactor and regulator of TRIP-Br1.
Zang ZJ; Gunaratnam L; Cheong JK; Lai LY; Hsiao LL; O'Leary E; Sun X; Salto-Tellez M; Bonventre JV; Hsu SI
Cell Signal; 2009 Jan; 21(1):34-42. PubMed ID: 18940248
[TBL] [Abstract][Full Text] [Related]
11. Domains necessary for Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12 a novel regulatory subunit of PP2A?
Zhu D; Tate RI; Ruediger R; Meigs TE; Denker BM
Mol Pharmacol; 2007 May; 71(5):1268-76. PubMed ID: 17303700
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
Messner DJ; Romeo C; Boynton A; Rossie S
J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
[TBL] [Abstract][Full Text] [Related]
13. Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome.
Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):733-8. PubMed ID: 14528909
[TBL] [Abstract][Full Text] [Related]
14. PP2A-dependent transactivation of the cyclin A promoter by SV40 ST is mediated by a cell cycle-regulated E2F site.
Skoczylas C; Henglein B; Rundell K
Virology; 2005 Feb; 332(2):596-601. PubMed ID: 15680424
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
Boudreau RT; Conrad DM; Hoskin DW
Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.
Kiely PA; O'Gorman D; Luong K; Ron D; O'Connor R
Mol Cell Biol; 2006 Jun; 26(11):4041-51. PubMed ID: 16705158
[TBL] [Abstract][Full Text] [Related]
17. Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor.
Saito S; Miyaji-Yamaguchi M; Shimoyama T; Nagata K
Biochem Biophys Res Commun; 1999 Jun; 259(2):471-5. PubMed ID: 10362532
[TBL] [Abstract][Full Text] [Related]
18. hnRNPA2/B1 and nELAV proteins bind to a specific U-rich element in CDK5R1 3'-UTR and oppositely regulate its expression.
Zuccotti P; Colombrita C; Moncini S; Barbieri A; Lunghi M; Gelfi C; De Palma S; Nicolin A; Ratti A; Venturin M; Riva P
Biochim Biophys Acta; 2014 Jun; 1839(6):506-16. PubMed ID: 24792867
[TBL] [Abstract][Full Text] [Related]
19. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.
Futamura M; Arakawa H; Matsuda K; Katagiri T; Saji S; Miki Y; Nakamura Y
Cancer Res; 2000 Mar; 60(6):1531-5. PubMed ID: 10749118
[TBL] [Abstract][Full Text] [Related]
20. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.
Tamaki M; Goi T; Hirono Y; Katayama K; Yamaguchi A
Oncol Rep; 2004 Mar; 11(3):655-9. PubMed ID: 14767517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
